CARVEFINE 3.125 TABLET contains Carvedilol which belongs to a group of medicines called Beta-blockers. It is used to treat high blood pressure (hypertension), chest pain or angina and also used to treat heart failure. Hypertension is defined as persistently elevated arterial blood pressure. Angina pectoris can be defined as a sudden, sharp and severe chest pain that originates from the apex of the heart and radiates to the left shoulder and it can be characterized by the presence of severe and crushing pain along with a feeling of pressure and suffocation, especially behind the breastbone. Heart failure is an inability of the heart to pump sufficient blood to meet the body’s needs.
CARVEFINE 3.125 TABLET is not recommended for use in patients with severe heart failure (fluid retention and breathlessness), a history of wheezing due to asthma or other lung diseases, severe hardening of arteries affecting the circulation in legs or feet, liver disease, conduction defect of the heart or heart block, AV heart block grade II or III, sick sinus syndrome (sino- atrial block), slow heartbeat, cardiogenic shock, very low blood pressure, unstable heart failure, Prinzmetal’s angina (chest pain at rest), untreated pheochromocytoma (a tumour of the adrenal gland), metabolic acidosis (disturbance in body’s acid-base balance), glucose or galactose intolerance.
Before taking CARVEFINE 3.125 TABLET inform your doctor, if you have diabetes, kidney, liver problems, severe hardening of arteries affecting the circulation in your legs or feet, arms, low blood pressure or elderly, first-degree heart block or other heart problems, severe heart failure, low salt and blood levels, Raynaud’s syndrome or peripheral vascular disease (cold hands and feet), thyroid problems, pheochromocytoma, previous history of serious allergic reaction or desensitisation therapy, psoriasis, Prinzmetal’s angina (chest pain at rest), dry eyes, lung disease (Asthma, COPD), pain, numbness or weakness of muscles due to low blood flow, surgery.
Avoid consumption of alcohol while taking CARVEFINE 3.125 TABLET. CARVEFINE 3.125 TABLET is generally not recommended for use by pregnant and breastfeeding women. CARVEFINE 3.125 TABLET is not recommended for use in children and adolescents under 18 years of age. CARVEFINE 3.125 TABLET should be used with caution in elderly patients (aged above 65 years). The most common side effects of taking CARVEFINE 3.125 TABLET are dizziness, headache, weakness, tiredness and low blood pressure causing lightheaded or fainting.